Age-Dependent Decrease of DNA Hydroxymethylation in Human T Cells
Thien Phu Truong, Mamiko Sakata-Yanagimoto, Momoko Yamada, Genta Nagae, Terukazu Enami, Rie Nakamoto-Matsubara, Hiroyuki Aburatani, Shigeru Chiba, Thien Phu Truong, Mamiko Sakata-Yanagimoto, Momoko Yamada, Genta Nagae, Terukazu Enami, Rie Nakamoto-Matsubara, Hiroyuki Aburatani, Shigeru Chiba
Abstract
Hydroxymethylcytosine (hmC) is a natural nucleobase, which is converted from methylcytosine (mC) by tet methylcytosine dioxygenase (TET) family (TET1-3) enzymes. Decrease of genomic hmC is postulated to confer a risk for myeloid-lineage as well as T-cell neoplasms, based on the fact that loss-of-function mutations in the TET2 gene were frequently identified in these diseases. The relationship between hmC and aging remains to be elucidated. Here, we demonstrated that hmC content decreased with age in the peripheral blood T cells of 53 human volunteers. We further identified that the mRNA expression levels of TET1 and TET3 decreased with age, while those of TET2 were not influenced by age. The genomic hmC content was correlated with the mRNA expression level of TET3, but not those of TET1 and TET2. Our study suggests the presence of new epigenetic regulatory mechanisms in aging T cells.
Source: PubMed
Prochains essais cliniques
-
NCT07826949Pas encore de recrutementGliome | Tumeur cérébrale | Gliomes récurrents de haut grade
-
NCT07826962Pas encore de recrutementParticipation des patients
-
NCT07826975Pas encore de recrutement
-
NCT07826988Pas encore de recrutementDrépanocytose | Crise vaso-occlusive
-
NCT07827001RecrutementCancer du cerveau | Cancer du SNC | Cancer du système nerveux | Cancer du cerveau métastatique
-
NCT07827027Pas encore de recrutement
-
NCT07827040RecrutementAdultes | Assistance numérique basse vision | Troubles de la vision
-
NCT07827053Pas encore de recrutementAdénocarcinome canalaire pancréatique (PDAC)
-
NCT07827066Pas encore de recrutementSevrage tabagique | Agent IA | Early-Stage Cancer
-
NCT07827131Pas encore de recrutement